Loading…

Renal failure in patients with ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention: Predictors, clinical and angiographic features, and outcomes

Background Among patients presenting with ST-segment elevation myocardial infarction (STEMI) for primary percutaneous coronary intervention (PCI), the associations between clinical outcomes and both baseline renal function and the development of acute kidney injury (AKI) have not been reported in a...

Full description

Saved in:
Bibliographic Details
Published in:The American heart journal 2016-03, Vol.173, p.57-66
Main Authors: Vavalle, John P., MD, MHS, van Diepen, Sean, MD, Clare, Robert M., MS, Hochman, Judith S., MD, Weaver, W. Douglas, MD, Mehta, Rajendra H., MD, Pieper, Karen S., MS, Patel, Manesh R., MD, Patel, Uptal D., MD, Armstrong, Paul W., MD, Granger, Christopher B., MD, Lopes, Renato D., MD, PhD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Among patients presenting with ST-segment elevation myocardial infarction (STEMI) for primary percutaneous coronary intervention (PCI), the associations between clinical outcomes and both baseline renal function and the development of acute kidney injury (AKI) have not been reported in a trial population with unselected baseline renal function. Methods Patients enrolled in the APEX-AMI trial who underwent primary PCI for the treatment of STEMI were categorized according to ( a ) baseline renal function and ( b ) the development of AKI. Patient characteristics, clinical outcomes, and treatment patterns were analyzed according to baseline renal function and the development of AKI. A prediction model for AKI after primary PCI for STEMI was also developed. Results A total of 5,244 patients were included in this analysis and stratified according to baseline estimated glomerular filtration rate (eGFR) (milliliters per minute per 1.73 m2 ) of >90, 60 to 90, 30 to 59, or 90, 60 to 90, 30 to 59, and
ISSN:0002-8703
1097-6744
DOI:10.1016/j.ahj.2015.12.001